Stocks · Health care · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Enovis CORP

ENOV Clue Score38
United States Fiscal year ends December CIK 0001420800 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Rajiv Vinnakota
8 May 2023
Director
Sold after exercise
1,396
$57.18
$79.82K
A Clayton Perfall
16 Mar 2023
Director
Sold after exercise
2,793
$52.13
$145.59K
Daniel A Pryor
15 Nov 2022
EVP, Strategy & Business Dev.
Sold after exercise
67,421
$54.58
$3.68M
Daniel A Pryor
8 Nov 2021
EVP, Strategy & Business Dev.
Sold after exercise
556
$53.03
$29.49K
Matthew L. Trerotola
8 Nov 2021
President & CEO
Sold after exercise
110
$53.82
$5.92K
Matthew L. Trerotola
8 Nov 2021
President & CEO
Sold after exercise
49,890
$53.02
$2.65M
Daniel A Pryor
5 Nov 2021
EVP, Strategy & Business Dev.
Sold after exercise
90
$54.08
$4.87K
Daniel A Pryor
5 Nov 2021
EVP, Strategy & Business Dev.
Sold after exercise
6,045
$54.22
$327.78K
Daniel A Pryor
5 Nov 2021
EVP, Strategy & Business Dev.
Sold after exercise
1,154
$53.44
$61.67K
Daniel A Pryor
4 Nov 2021
EVP, Strategy & Business Dev.
Sold after exercise
300
$54.14
$16.24K
Daniel A Pryor
4 Nov 2021
EVP, Strategy & Business Dev.
Sold after exercise
12,955
$54.09
$700.72K
Daniel A Pryor
4 Nov 2021
EVP, Strategy & Business Dev.
Sold after exercise
3,361
$53.59
$180.11K
Daniel A Pryor
2 Nov 2021
EVP, Strategy & Business Dev.
Sold after exercise
6,340
$53.02
$336.15K
Matthew L. Trerotola
15 Oct 2021
President & CEO
Sold after exercise
12,801
$50.88
$651.29K
Matthew L. Trerotola
15 Oct 2021
President & CEO
Sold after exercise
37,199
$50.61
$1.88M
Shyam Kambeyanda
15 Oct 2021
ESAB President and EVP, Colfax
Sold after exercise
15,218
$50.68
$771.29K
Shyam Kambeyanda
15 Oct 2021
ESAB President and EVP, Colfax
Sold after exercise
24,644
$50.69
$1.25M
Matthew L. Trerotola
13 Sep 2021
President & CEO
Sold after exercise
59,563
$46.66
$2.78M
Matthew L. Trerotola
16 Aug 2021
President & CEO
Sold after exercise
1,446
$49.51
$71.59K
Matthew L. Trerotola
16 Aug 2021
President & CEO
Sold after exercise
4,294
$49.50
$212.53K
Matthew L. Trerotola
16 Aug 2021
President & CEO
Sold after exercise
5,290
$49.49
$261.79K
Matthew L. Trerotola
16 Aug 2021
President & CEO
Sold after exercise
69,710
$48.97
$3.41M
Matthew L. Trerotola
16 Aug 2021
President & CEO
Sold after exercise
70,706
$48.98
$3.46M
Matthew L. Trerotola
19 Jul 2021
President & CEO
Sold after exercise
7,049
$43.15
$304.14K
Matthew L. Trerotola
19 Jul 2021
President & CEO
Sold after exercise
67,951
$42.63
$2.90M
Matthew L. Trerotola
21 Jun 2021
President & CEO
Sold after exercise
75,000
$44.41
$3.33M
Christopher M Hix
14 Jun 2021
EVP, Chief Financial Officer
Sold after exercise
100
$46.64
$4.66K
Christopher M Hix
14 Jun 2021
EVP, Chief Financial Officer
Sold after exercise
89,900
$45.89
$4.13M
Matthew L. Trerotola
14 May 2021
President & CEO
Sold after exercise
200,000
$43.14
$8.63M
Patricia A Lang
3 May 2021
SVP, Chief HR Officer
Sold after exercise
24,677
$43.94
$1.08M
A. Lynne Puckett
16 Jan 2018
SVP, GC & Secretary
Sold after exercise
7,270
$42.01
$305.41K
Daniel A Pryor
19 Dec 2017
EVP, Strategy & Business Dev.
Sold after exercise
53,333
$38.15
$2.03M
Stephen Wittig
7 Sep 2017
SVP - CBS & Supply Chain
Sold after exercise indirect
1,000
$39.64
$39.64K
Stephen Wittig
7 Sep 2017
SVP - CBS & Supply Chain
Sold after exercise
547
$39.64
$21.70K
Stephen Wittig
7 Sep 2017
SVP - CBS & Supply Chain
Sold after exercise
27,642
$39.28
$1.09M
A. Lynne Puckett
30 May 2017
SVP, GC & Secretary
Sold after exercise
10,882
$40.14
$436.78K
Stephen Wittig
2 Dec 2016
SVP - CBS & Supply Chain
Sold after exercise
22,428
$37.71
$845.76K

What was left out

Form 4 filings counted 552
Amendments (4/A) skipped 9
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 37
Sales at will 134
Transactions with no price 0
Shares from compensation/vesting 6,063,831
Sales filed before the plan box existed 129
History held since 14 May 2008